Literature DB >> 27574555

Activated systemic inflammatory response at diagnosis reduces lymph node count in colonic carcinoma.

Rory P Kennelly1, Brenda Murphy1, John O Larkin1, Brian J Mehigan1, Paul H McCormick1.   

Abstract

AIM: To investigate a link between lymph node yield and systemic inflammatory response in colon cancer.
METHODS: A prospectively maintained database was interrogated. All patients undergoing curative colonic resection were included. Neutrophil lymphocyte ratio (NLR) and albumin were used as markers of SIR. In keeping with previously studies, NLR ≥ 4, albumin < 35 was used as cut off points for SIR. Statistical analysis was performed using 2 sample t-test and χ(2) tests where appropriate.
RESULTS: Three hundred and two patients were included for analysis. One hundred and ninety-five patients had NLR < 4 and 107 had NLR ≥ 4. There was no difference in age or sex between groups. Patients with NLR of ≥ 4 had lower mean lymph node yields than patients with NLR < 4 [17.6 ± 7.1 vs 19.2 ± 7.9 (P = 0.036)]. More patients with an elevated NLR had node positive disease and an increased lymph node ratio (≥ 0.25, P = 0.044).
CONCLUSION: Prognosis in colon cancer is intimately linked to the patient's immune response. Assuming standardised surgical technique and sub specialty pathology, lymph node count is reduced when systemic inflammatory response is activated.

Entities:  

Keywords:  Colon cancer; Colonic cancer; Lymph node count; Lymph node ratio; Lymph node yield; Neutrophil to lymphocyte ratio; Neutrophil-lymphocyte ratio; Systemic inflammatory response

Year:  2016        PMID: 27574555      PMCID: PMC4980653          DOI: 10.4251/wjgo.v8.i8.623

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  26 in total

1.  Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas?

Authors:  Gábor Cserni; Vincent Vinh-Hung; Tomasz Burzykowski
Journal:  J Surg Oncol       Date:  2002-10       Impact factor: 3.454

2.  Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons.

Authors:  Carlos A Vaccaro; Victor Im; Gustavo L Rossi; Guillermo Ojea Quintana; Mario L Benati; Diego Perez de Arenaza; Fernando A Bonadeo
Journal:  Dis Colon Rectum       Date:  2009-07       Impact factor: 4.585

3.  Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer.

Authors:  Paul M Johnson; Geoff A Porter; Rocco Ricciardi; Nancy N Baxter
Journal:  J Clin Oncol       Date:  2006-08-01       Impact factor: 44.544

Review 4.  Lymph node evaluation and survival after curative resection of colon cancer: systematic review.

Authors:  George J Chang; Miguel A Rodriguez-Bigas; John M Skibber; Virginia A Moyer
Journal:  J Natl Cancer Inst       Date:  2007-03-21       Impact factor: 13.506

5.  Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer.

Authors:  Donald C McMillan; Joseph E M Crozier; Khalid Canna; Wilson J Angerson; Colin S McArdle
Journal:  Int J Colorectal Dis       Date:  2007-01-24       Impact factor: 2.571

6.  Inhibition of mutated, activated BRAF in metastatic melanoma.

Authors:  Keith T Flaherty; Igor Puzanov; Kevin B Kim; Antoni Ribas; Grant A McArthur; Jeffrey A Sosman; Peter J O'Dwyer; Richard J Lee; Joseph F Grippo; Keith Nolop; Paul B Chapman
Journal:  N Engl J Med       Date:  2010-08-26       Impact factor: 91.245

7.  Lymph node ratio as a quality and prognostic indicator in stage III colon cancer.

Authors:  Steven L Chen; Scott R Steele; John Eberhardt; Kangmin Zhu; Anton Bilchik; Alexander Stojadinovic
Journal:  Ann Surg       Date:  2011-01       Impact factor: 12.969

Review 8.  Colorectal cancer and lymph nodes: the obsession with the number 12.

Authors:  Giovanni Li Destri; Isidoro Di Carlo; Roberto Scilletta; Beniamino Scilletta; Stefano Puleo
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

9.  The relation between lymph node status and survival in Stage I-III colon cancer: results from a prospective nationwide cohort study.

Authors:  J Lykke; O Roikjaer; P Jess
Journal:  Colorectal Dis       Date:  2013-05       Impact factor: 3.788

10.  Impact of Schwartz enhanced visualization solution on staging colorectal cancer and clinicopathological features associated with lymph node count.

Authors:  Brandon Chapman; Cherie Paquette; Chelsea Tooke; Michelle Schwartz; Turner Osler; Donald Weaver; Rebecca Wilcox; Neil Hyman
Journal:  Dis Colon Rectum       Date:  2013-09       Impact factor: 4.585

View more
  2 in total

1.  A Nomogram to Predict Adequate Lymph Node Recovery before Resection of Colorectal Cancer.

Authors:  Zhen-Yu Zhang; Cong Li; Wei Gao; Xiao-Wei Yin; Qi-Feng Luo; Nan Liu; Shiva Basnet; Zhen-Ling Dai; Hai-Yan Ge
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

2.  Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.

Authors:  Nikoletta Dimitriou; Evangelos Felekouras; Ioannis Karavokyros; Andreas Alexandrou; Emmanuel Pikoulis; John Griniatsos
Journal:  BMC Cancer       Date:  2018-12-03       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.